To the full analysis
Buyback calculator for ARS Pharmaceuticals
ARS Pharmaceuticals stock: key metrics
SPRYARS Pharmaceuticals had an operating margin of −212.9% and a return on invested capital (ROIC) of −46% in fiscal 2025.
Margins show how much of revenue is left over, returns on capital how hard the invested money works.
Daily figure as of 13 Nov 2026
Margins
- Gross margin
- Operating margin
- Net margin
Figures as a table
| Year | Gross margin | Operating margin | Net margin |
|---|---|---|---|
| 2018 | no data | no data | no data |
| 2019 | no data | no data | no data |
| 2020 | 21.1% | −2.6% | −6.0% |
| 2021 | 96.1% | −353.3% | −367.7% |
| 2022 | −1,200.9% | −2,698.8% | −2,635.4% |
| 2023 | 100.0% | −225,066.7% | −181,216.7% |
| 2024 | 76.9% | −3.5% | 9.0% |
| 2025 | 75.8% | −212.9% | −203.3% |
Returns on capital
- ROE
- ROIC
- ROA
Figures as a table
| Year | ROE | ROIC | ROA |
|---|---|---|---|
| 2018 | −96.6% | −55.8% | −63.8% |
| 2019 | 200.0% | no data | −100.0% |
| 2020 | 7.6% | −2.4% | −4.0% |
| 2021 | 64.7% | −39.7% | −32.9% |
| 2022 | −12.7% | −16.9% | −12.3% |
| 2023 | −23.6% | −21.0% | −23.3% |
| 2024 | 3.1% | −1.1% | 2.3% |
| 2025 | −100.0% | −46.0% | −52.3% |
Data status and sources
- Score
- Daily value of 13 Nov 2026, recalculated nightly
- Price
- Closing price of 12 Nov 2026
- Latest annual report
- Fiscal year 2025, period end 31 Dec 2025
- Source
- Financial statements, ratios and prices from Financial Modeling Prep (FMP), based on the company's reports. MEQIRI calculates the score and fair value from them.
Mandatory disclosures for this rating
- ; time horizon around 12 months
- Rated Weak, published since 7 Nov 2026 (in the score history since 15 Aug 2025)
- End-of-day prices, metrics cached for up to 24 hours
- Score and fair value are estimates from a disclosed model. They are not facts and not a price target.
- Produced by SSM Ventures UG (haftungsbeschränkt), responsible person Sven Brostmeyer, Managing Director, automatically according to the disclosed model.
- Not investment advice. Losses up to and including a total loss are possible. Personal circumstances are not considered.